STRIVECTIN CLINICAL CORRECTOR ADVANCED ANTI-AGING FACE TINT LIGHT- octinoxate, octisalate, titanium dioxide cream 
Strivectin Operating Company, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

StriVectin - Clinical Corrector ADVANCED ANTI-AGING FACE TINT LIGHT (76147-210), DELIST

Drug Facts

Active Ingredients

Octinoxate 7.50%
Octisalate 3.00%
Titanium Dioxide 8.00%

Purpose

Sunscreen

Uses

helps prevent sunburn

Warnings

For external use only

Do not use

on damaged or broken skin

When using this product

keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if

rash occurs

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• apply liberally 15 minutes before sun exposure
• reapply at least every two hours
• use a water resistant sunscreen if swimming or sweating
• Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
   • limit time in the sun, especially from 10 a.m.- 2 p.m.
   • wear long-sleeved shirts, pants, hats, and sunglasses
• children under 6 months of age: ask a doctor

Inactive Ingredients

Aqua (Water, Eau), Cyclopentasiloxane, Butylene Glycol, PEG-10 Dimethicone, Myristyl Nicotinate, Isododecane, Phenyl Trimethicone, Aluminum Hydroxide, Stearic Acid, Tocopherol, Tocopheryl Acetate, Tetrahexyldecyl Ascorbate, Retinyl Palmitate, Sodium Hyaluronate, Glycyrrhiza Glabra (Licorice) Root Extract, Olive Glycerides, Ceramide 3, Caprylyl Glycol, Polyamide-5, Nylon-12, Bis-PEG/PPG-14/14 Dimethicone, Boron Nitride, Disteardimonium Hectorite, Sodium Dehydroacetate, Methicone, Triethosycaprylylsilane, Sodium Chloride, Hexylene Glycol, Mica, Disodium EDTA, Phenoxyethanol. May Contain +/-: CI 77891 (Titanium Dioxide), CI 77491/77492/77499 (Iron Oxides)

Other information

Protect the product in this container from excessive heat and direct sun.

Product Labels

Light - CartonLight - Tube

STRIVECTIN CLINICAL CORRECTOR ADVANCED ANTI-AGING FACE TINT LIGHT 
octinoxate, octisalate, titanium dioxide cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:76147-210
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE75 mg  in 1 mL
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE30 mg  in 1 mL
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE80 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
MYRISTYL NICOTINATE (UNII: 8QWM6I035C)  
ISODODECANE (UNII: A8289P68Y2)  
PHENYL TRIMETHICONE (UNII: DR0K5NOJ4R)  
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
TOCOPHEROL (UNII: R0ZB2556P8)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
TETRAHEXYLDECYL ASCORBATE (UNII: 9LBV3F07AZ)  
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
GLYCYRRHIZA GLABRA (UNII: 2788Z9758H)  
CERAMIDE 3 (UNII: 4370DF050B)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
NYLON-12 (UNII: 446U8J075B)  
BIS-PEG/PPG-14/14 DIMETHICONE (UNII: X2I70H0QJE)  
BORON NITRIDE (UNII: 2U4T60A6YD)  
DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
SODIUM DEHYDROACETATE (UNII: 8W46YN971G)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
HEXYLENE GLYCOL (UNII: KEH0A3F75J)  
MICA (UNII: V8A1AW0880)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:76147-210-011 in 1 CARTON03/23/201512/31/2021
130 mL in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart35203/23/201512/31/2021
Labeler - Strivectin Operating Company, Inc. (832343722)

Revised: 2/2022
 
Strivectin Operating Company, Inc.